Genomatix improves its coverage of Affymetrix new exon arrays

Genomatix Software GmbH announced today that it will extend the leading position of its gene chip compatible products further by a new version of ChipInspector, which will be specifically geared towards analysis of the new exon arrays.

"ChipInspector already revolutionized the analysis of the conventional oligo/probe based gene chips due to the powerful annotation driven analysis optimization that precedes the statistical processing of the microarray data. This feature is based on Genomatix unique knowledge and data on promoters and transcripts, which will also empower the special version optimized for the exon arrays" says Dr. Thomas Werner, CEO & CSO of Genomatix. According to Dr. Matthias Scherf, head of Genomatix Discovery team, who oversees the ChipInspector development, the new specialized version of ChipInspector will considerably improve analysis of the exon array data including transcript separation and promoter identification of the relevant transcripts.

"We have seen excellent results on pilot data from exon arrays using ChipInspector as available today" says Dr. Martin Seifert, Vice President of Microarray Business and Collaborative Research at Genomatix.

"We have brought the first complete microarray analysis pipeline to the market, that starts at the raw data and delivers the underlying biology including analysis of relevant regulatory mechanisms" explains Klaus May, Director of Sales and Marketing at Genomatix. "ChipInspector ExonArray will be a fully integrated part of this pipeline the same way as the current ChipInspector is, guaranteeing our customers superior results from raw data all the way into biology. Our pipeline delivers complete results within hours, and such speed is a great value in its own right," Klaus May continues.

ChipInspector ExonArray is expected to be released beginning of Q2 2006 and can be preordered effective immediately from Genomatix as an upgrade to ChipInspector.


Contact: Klaus May
Genomatix Software GmbH

Page: 1

Related biology news :

1. Genomatix expands operations in North America
2. Application of Genomatix in silico methods reveals novel cancer associated genes
3. Genomatix and Molecular Connections form strategic partnership
4. Genomatix wins BioChance grant worth $1.6 million
5. Genomatix appoints distributor for the growing Chinese market
6. MatBase -- A new transcription factor knowledge base released by Genomatix
7. The Center of Nutrigenomics of the TU Munich licences Genomatix Microarray Analysis Pipeline
8. Bayer HealthCare licenses Genomatix for microarray analysis
9. Genomatix technology facilitates de novo identification of new renal disease associated genes
10. Genomatix partners with Research Instruments Pte Ltd for Singapore, Malaysia and Thailand markets
11. German Microarray Excellence Center integrates Genomatix Chip Analysis Pipeline

Post Your Comments:

(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures ... UK, the world’s largest independent funder of cancer research. , Deep Science Ventures was ... a systems-level view of the opportunity from the start, both at the industry and ...
(Date:9/22/2019)... (PRWEB) , ... September 20, 2019 , ... ... instrument makers are adjusting to client demands for precision medicine products. The report, ... demand exceeding $19 billion in 2018, the pharma/bio sector is the largest source ...
(Date:9/14/2019)... CULVER CITY, Calif. (PRWEB) , ... September 13, ... ... of the World Molecular imaging Society (WMIS) focused on non-invasive real-time tracking of ... With mean survival rate of five years (and most cases fatal) lysomal storage ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... ... September 24, 2019 , ... ... of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug formulations. ... present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: ...
(Date:9/24/2019)... , ... September 24, 2019 , ... ... Hannah Holscher, PhD, RD, to its Scientific Advisory Board. Dr. Holscher is an ... and the Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, where ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, ... four months old, Tucker was limping and lame on his right hip and elbow. ... and it was called “the worst case the vet had seen.” He was prescribed ...
(Date:9/17/2019)... Fla. (PRWEB) , ... September 16, 2019 , ... ... broadcast Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings ... Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated ...
Breaking Biology Technology:
Cached News: